The Map3k12 (Dlk)/JNK3 signaling pathway is required for pancreatic beta-cell proliferation during postnatal development.

Details

Ressource 1Download: Full revised manuscript CMLS-D-19-00971.cmls.pdf (1401.90 [Ko])
State: Public
Version: Author's accepted manuscript
License: Not specified
Serval ID
serval:BIB_2DF49344E30F
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
The Map3k12 (Dlk)/JNK3 signaling pathway is required for pancreatic beta-cell proliferation during postnatal development.
Journal
Cellular and molecular life sciences
Author(s)
Tenenbaum M., Plaisance V., Boutry R., Pawlowski V., Jacovetti C., Sanchez-Parra C., Ezanno H., Bourry J., Beeler N., Pasquetti G., Gmyr V., Dalle S., Kerr-Conte J., Pattou F., Hirai S.I., Regazzi R., Bonnefond A., Froguel P., Abderrahmani A.
ISSN
1420-9071 (Electronic)
ISSN-L
1420-682X
Publication state
Published
Issued date
01/2021
Peer-reviewed
Oui
Volume
78
Number
1
Pages
287-298
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
Unveiling the key pathways underlying postnatal beta-cell proliferation can be instrumental to decipher the mechanisms of beta-cell mass plasticity to increased physiological demand of insulin during weight gain and pregnancy. Using transcriptome and global Serine Threonine Kinase activity (STK) analyses of islets from newborn (10 days old) and adult rats, we found that highly proliferative neonatal rat islet cells display a substantially elevated activity of the mitogen activated protein 3 kinase 12, also called dual leucine zipper-bearing kinase (Dlk). As a key upstream component of the c-Jun amino terminal kinase (Jnk) pathway, Dlk overexpression was associated with increased Jnk3 activity and was mainly localized in the beta-cell cytoplasm. We provide the evidence that Dlk associates with and activates Jnk3, and that this cascade stimulates the expression of Ccnd1 and Ccnd2, two essential cyclins controlling postnatal beta-cell replication. Silencing of Dlk or of Jnk3 in neonatal islet cells dramatically hampered primary beta-cell replication and the expression of the two cyclins. Moreover, the expression of Dlk, Jnk3, Ccnd1 and Ccnd2 was induced in high replicative islet beta cells from ob/ob mice during weight gain, and from pregnant female rats. In human islets from non-diabetic obese individuals, DLK expression was also cytoplasmic and the rise of the mRNA level was associated with an increase of JNK3, CCND1 and CCND2 mRNA levels, when compared to islets from lean and obese patients with diabetes. In conclusion, we find that activation of Jnk3 signalling by Dlk could be a key mechanism for adapting islet beta-cell mass during postnatal development and weight gain.
Keywords
Animals, Cell Proliferation/drug effects, Cyclin D1/genetics, Cyclin D1/metabolism, Cyclin D2/genetics, Cyclin D2/metabolism, Female, Glucose/pharmacology, Humans, Insulin/metabolism, Insulin-Secreting Cells/cytology, Insulin-Secreting Cells/metabolism, MAP Kinase Kinase Kinases/antagonists & inhibitors, MAP Kinase Kinase Kinases/genetics, MAP Kinase Kinase Kinases/metabolism, Mice, Mice, Inbred C57BL, Mitogen-Activated Protein Kinase 10/antagonists & inhibitors, Mitogen-Activated Protein Kinase 10/genetics, Mitogen-Activated Protein Kinase 10/metabolism, Obesity/metabolism, Obesity/pathology, Pancreas/growth & development, Pancreas/metabolism, RNA Interference, RNA, Small Interfering/metabolism, Rats, Rats, Sprague-Dawley, Signal Transduction/drug effects, Beta-cell mass, Mapk, Obesity, Postnatal development, Pregnancy
Pubmed
Web of science
Create date
01/04/2020 20:22
Last modification date
12/08/2022 6:08
Usage data